Skip to main content

Posts

Showing posts from November, 2019

Talking Biotech 215 - The GE Crop Ban in South Australia

While Australian farmers have adopted GE crops with great economic and environmental success, the government of the state of South Australia has imposed a moratorium on their use.  The ban has been in place since 2005, and farmers in the region need to rely on more intensive methods of weed control and experience lower yields.  Recent political changes sought to reverse the ban.  Today's podcast features Caroline Rhodes, the CEO of Grain Producers South Australia, and discusses the unfair and burdensome rules that harm the state's producers. 

Listen to this episode here. 

Talking Biotech 214 - Artificial Intelligence and Machine Learning

Massive repositories of biological data have been generated over the last two decades. While humans can target certain goals to derive from the data, computational tools can oftentimes find what humans cannot, and do so without the inherent bias of the human brain. Dr. Gabe Musso from BioSymmetrics expertly describes artificial intelligence and machine learning, its limitations and misconceptions. 

Listen to this episode here. 

Talking Biotech 213 - Egg Production and GE Ethics

New laying chickens are constantly produced to satisfy the demand for eggs. Unfortunately, males and females hatch, only the females are needed for egg production.  The males are destroyed shortly after birth, which leads to ethical and practical questions. Dr. Nigel Urwin describes efforts to use biotechnology to allow separation of eggs containing male or female embryos. The technology may change perceptions of genetic engineering and egg production.

This episode may be heard here.  

Talking Biotech 212 - Michele Payn, Food Bullying

Michele Payn is  a much sought after keynote speaker and writer, and a strong advocate for agriculture.  She has completed the third book, this one dedicated to the pervasive problem of shaming and criticism around our personal food choices.  Listen to the whole story here.

Talking Biotech 211 - CAR-T Cells: Engineered to Attack Cancer

This week's podcast is pure gold, a great interview with Dr. Joe Fraietta from University of Pennsylvania.  Dr. Fraietta discusses CAR-T cells, human immune cells genetically engineered to attack specific cancers.  It is a great primer on a new therapy that is changing cancer treatment. 


Listen to the Podcast Here.